TriSalus Life Sciences Inc. (TLSI)
NASDAQ · Healthcare
TriSalus Life Sciences Inc. Operating Income 2022–2025
TriSalus Life Sciences Inc. annual/quarterly operating income history and growth rate from 2022 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- TriSalus Life Sciences Inc. operating income for the quarter ending March 31, 2026 was -8.4 M, a 14.76% increase year-over-year.
- TriSalus Life Sciences Inc. operating income for the twelve months ending March 31, 2026 was -32.1 M, a 32.02% decrease year-over-year.
- TriSalus Life Sciences Inc. annual operating income for 2025 was -26.9 M, a 25.49% decrease from 2024.
- TriSalus Life Sciences Inc. annual operating income for 2024 was -36.2 M, a 33.61% decrease from 2023.
- TriSalus Life Sciences Inc. annual operating income for 2023 was -54.5 M, a 49.50% increase from 2022.
- TriSalus Life Sciences Inc. annual operating income for 2022 was -36.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
TriSalus Life Sciences Inc. Operating Income — FAQ
TriSalus Life Sciences Inc. (TLSI) operating income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is TriSalus Life Sciences Inc.'s operating income?
TriSalus Life Sciences Inc. (TLSI) reported operating income of -$27M for fiscal 2025.
Where can I see TLSI's operating income history?
The chart and table above show TriSalus Life Sciences Inc.'s operating income by year and by quarter, including the growth rate.